The emergence of pharmacotherapies for cognitive function in Down syndrome
โ Scribed by George T. Capone
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 59 KB
- Volume
- 152A
- Category
- Article
- ISSN
- 1552-4825
No coin nor oath required. For personal study only.
โฆ Synopsis
Capone GT. 2010. The emergence of pharmacotherapies for cognitive function in Down syndrome.
๐ SIMILAR VOLUMES
Maternal serum screening for Down syndrome involves biochemical tests such as alpha-fetoprotein ( FP), human chorionic gonadotrophin (hCG) and unconjugated oestriol (uE 3 ), either alone or in combination, that have variable detection and false-positive rates. Choosing a screening protocol requires
We assessed the utility of radiographic findings as aids to the diagnosis of Down syndrome (DS) in stillborn infants. The iliac index may help to confirm the diagnosis of DS in stillborn infants in whom it is suspected clinically, but in whom it cannot be confirmed cytogenetically. It also can serve